Formulation Development of Nano Structured Lipid Carrier of Lurasidone hydrochloride for Intranasal Delivery

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Kadam Tanvi
التنسيق:	أطروحة كتاب
اللغة:	الإنجليزية
منشور في:	Mumbai NMIMS-SPPSPTM 2025 (Registration Date: 21.07.2018)
الموضوعات:	Schizophrenia; Lurasidone hydrochloride (LH),
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Formulation Development and Optimization of Temozolomide Nano Lipid Carriers
حسب: Yasaswi P. Soma

Development and Evaluation of Lurasidone-Loaded Solid Lipid Nanoparticles by Intranasal Route
حسب: Sakreet Upadhyay
منشور في: (2017)

Transdermal Drug Delivery of Anti-Psychotic Drug Lurasidone Hydrochloride
حسب: Vasavi Baraskar
منشور في: (2019)

Development of nanocarrier based thermosensitive mucoadhesive gel containing Metformin Hydrochloride and Silymarin for treatment of Oral Cancer
حسب: Shete Meghanath B.
منشور في: (2024)

Nanostructured Lipid Carriers Of Alendornate for Transdermal Delivery
حسب: Kalave Sana

Formulation and Evaluation of a Nano- Structured Lipid Carrier- Based Targeted Delivery System for Rofecoxib in the Treatment of Rheumatoid Arthritis
حسب: Gangurde Sanket Sahebrao

Made you up
حسب: Zappia, Francesca
منشور في: (2015)

DEVELOPMENT OF A FORMULATION OF PALIPERIDONE FOR INTRANASAL DELIVERY
حسب: KARTIKA PIPIDAPARATHI

Lipid Carrier Based Topical Formulation of Morin for Atopic Dermatitis
حسب: Narad Prasad

SOLUBILITY ENHANCEMENT OF LURASIDONE HYDROCHLORIDE BY COMPLEXATION AND FORMULAITON OF IMMEDIATE RELEASE TABLET
حسب: SINGH SARITA

Formulation Development and Evaluation of Gefitnib Based Nano-Carrier System
حسب: Kshama Kamlesh Shah

Formulation and evaluation of hydroquinone loaded nao-lipid carrier for skin whitening
حسب: Vineeth B.R

FORMULATION DEVELOPMENT AND EVALUATION OF INTRANASAL DRUG DELIVERY SYSTEM OF DESLORATADINE
حسب: BAHETI SURAJ

Formulation and Evaluation of Liposomal Temozolomide for Intranasal Delivery in Glioblastoma Multiforme
حسب: Jain Ashish

Development and Evaluation of Intranasal Nanoformulation of Sertraline Hydrochloride for Antidepressant Action
حسب: Tambe Varunesh

Organisational Schizophrenia
حسب: Gureja, Gopal K
منشور في: (2013)

Organisational Schizophrenia
حسب: Gureja, Gopal K
منشور في: (2013)

ORAL LIPID-BASED FORMULATION
حسب: HAUSS [A]

FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES OF ZALTOPROFEN FOR TOPICAL DELIVERY
حسب: SAVE SWARALI

Surface Modified PLGA Based Nano Carrier for Nose to Brain Delivery of Temozolomide
حسب: Khanduri Arushee

FORMULATION, DEVELOPMENT AND EVALUATION OF INTRANASAL DRUG DELIVERY SYSTEM OF FLUTICASONE PROPIONATE
حسب: GUPTA GAURAV

Liposomes of Erlotinib Hydrochloride for Sustained Delivery
حسب: Nidhi Korgaonkar

DEVELOPMENT AND EVALUATION OF NANOSTRUCTURED LIPID CARRIER (NLC) BASED ORAL ANTICANCER FORMULATION OF EXEMESTANE
حسب: KEDIA KISHORI

Formulation and Evaluation Nano Drug Delivery for Idiopathic Pulmonary Fibrosis
حسب: Singh Sanskriti
منشور في: (2023)

Solid Lipid Nanoparticles as a Carrier for Anti-Rheumatic Drugs
حسب: Mirchandani Yashika
منشور في: (2022)

SOLID LIPID NANOPARTICLES AS A CARRIER FOR ANTI-RHEUMATIC DRUGS
حسب: MIRCHANDANI,YASHIKA
منشور في: (2022)

Brain-targeted nanocarriers intranasal formulation for migraine
حسب: Ishant Kataria

Development and Evaluation of a Nanostuctured Lipid Carrier System for Oral Delivery of Opicapone to Enhance Bioavailability
حسب: Mr. Prashant Ashok Mahajan

FORMULATION DEVELOPMENT AND EVALUATION OF NASAL PREPARATION- NANOSTRUCTURED LIPID CARRIERS OF AN ANTI-CONVULSANT DRUG CL
حسب: DAMA KINJAL

Development and Evaluation of Telmisartan IP Intranasal NanoEmulsion for Treatment of Dementia
حسب: Haque Sahil
منشور في: (2023)

NANO
حسب: PRADEEP T
منشور في: (2016)

Nano
حسب: Ghate, N
منشور في: (2014)

Co-delivery of Gefitinib and Paclitaxel as Inhalable Nano Carriers for Non Small Cell Lung Cancer
حسب: Walvekar Shreya

FORMULATION AND DEVELOPMENT OF EPERISONE HYDROCHLORIDE NIOSOMES, JP
حسب: MULYE APOORVA

Intra-articular Nano Formulation of Aceclofenac
حسب: Yemgekar Mayuri

Use of Lipid Carrier to Deliver Calcitonin and calciferol via the Small Intestine
حسب: Jain Sameer

Development ,optimization and Evaluation of Nanostructured Lipid Carriers in ameliorating Schizophrenia Therapy
حسب: Sharma Rarchita Mukkamala M S

Development and Evaluation of Lipid Based Formulation of Rosauastatin
حسب: Divya Suares

Development and Evaluation of Lipid Based Formulation of Rosuvastatin
حسب: Suares Glenn Divya
منشور في: (2016)

Intranasal Nanoparticle Based Delivery of Telmisartan for Brain Targeting : Formulation Development and Invivo Evaluation
حسب: Ganti Srikar